Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for Alopecia Areata
NCT00176982Phase 4Completed
- Start
- Apr 2002
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of hydroxychloroquine in alopecia areata (2 arms). Primary endpoint: Percent hair regrowth in each quadrant of the scalp. Started Apr 2002; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
alopecia areata
Beyond the preview
Go deeper on NCT00176982.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00176982.